Cytokine storm polymorphisms in nonvaccinated COVID-19 patients
Laura Edith Martínez-GómeziD, Carla Isabel Oropeza-Vélez, Maylin Almonte BecerriliD, Leslie Chávez‐GalániD, Carlos Martínez-ArmentaiD, Rosa Patricia Vidal-VázqueziD, Juan Pablo Ramírez-HinojosaiD, Paola Vázquez-CárdenasiD, Diana Gómez‐MartíniD, Gilberto Vargas‐AlarcóniD, José Manuel Rodrı́guez-PéreziD, Lucero A. Ramón‐LuingiD, Julio Flores‐GonzáleziD, José G. Carrasco, Mónica Maribel Mata-MirandaiD, Gustavo Jesús Vázquez-ZapiéniD, Adriana Martínez-CuazitliD, Nancy TorresiD, Felipe de J. Martínez-Ruiz, Dulce M. Zayago-Angeles, Ma. Luisa Ordoñez-Sánchez, Yayoi Segura-KatoiD, Carlos Suárez-AhedoiD, Jessel Olea-Torres, Brígida Herrera-López, , Alberto Gabriel López-ReyesiD
Abstract
Cytokines and chemokines are essential for establishing an appropriate immune response to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Variations in the genes encoding cytokines and chemokines strongly influence the immune response to pathogenic challenges and disease outcomes. This study was carried out to determine the associations of polymorphisms in the TNF-, IL-6, IL-8, IL-10, and CCL5 genes with COVID-19 severity. A total of 627 unvaccinated COVID-19 patients were classified according to WHO disease severity. We evaluated the levels of IFN-, IFN-{gamma}, TNF-, IL-1R, IL-6, IL-7, IL-10, CCL2, CCL3, CXCL8, CXCL10 and GCSF in the serum and were compared among COVID-19 disease severity groups and stratified by polymorphism alleles. This study revealed a significant increase in IL-2, IL-6 and CCL-2 levels in the dead group. However, the IL-10 levels were higher in the moderate group than in the mild group. Logistic regression analysis revealed that five polymorphisms were associated with an increased risk of severe COVID-19: the TNF- (rs1800610) A allele (OR=1.50; 95% CI: 1.01-2.24); the IL-6 (rs1800796) C allele (OR=1.64; 95% CI: 1.05-2.57); the IL-10 (rs1800871) T allele (OR=1.94; 95% CI: 1.24-3.04) and the IL-10 (rs1800872) A allele (OR=1.87; 95% CI: 1.21-2.89); and the CCL5 (rs3817656) G allele (OR= 1.64; 95% CI: 1.02-2.65)). The IL-10 (rs1800871 and rs1800872) and IL-6 (rs1800796 and rs18049563) gene polymorphisms were also associated with COVID-19 severity. Increases in IL-6 and CCL-2 serum levels in carriers of the risk allele rs1049953. In contrast, the IL-10 levels were not associated with any of the SNPs.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Association of polymorphisms of IL-6 pathway genes (IL6, IL6R and IL6ST) with COVID-19 severity in an Amazonian population.
Fabíola Brasil Barbosa Rodrigues, Rosilene da Silva, … Eduardo José Melo dos Santos·bioRxiv·Sep 21, 2022
- Cytokine and chemokine profile in patients hospitalized with COVID-19: A comparative study
A. T. Bedada·bioRxiv·Mar 17, 2022
- Establishing thresholds for cytokine storm and defining their relationship to disease severity in respiratory viral infections
A. Souquette, J. C. Crawford, … P. G. Thomas·bioRxiv·Jul 6, 2023
- Elevated anti-SARS-CoV-2 antibodies and IL-6, IL-8, MIP-1β, early predictors of severe COVID-19.
H. Codina, I. Vieitez, … E. Poveda·bioRxiv·Apr 13, 2021
- Analysis of Genetic Host Response Risk Factors in Severe COVID-19 Patients
Krystyna Taylor, Sayoni Das, … Steve Gardner·medRxiv·Jun 17, 2020
- Mucosal and systemic immune dynamics associated with COVID-19 outcomes: a longitudinal prospective clinical study
M. Agrawal, A. S. Flores-Torres, … H. S. Smallwood·bioRxiv·Aug 4, 2023